Member
1 Award

Moonrise Medical


Moonrise Medical is dedicated to developing AI-enabled ultrasound technology aimed at improving the diagnosis and treatment of peripheral vascular diseases, particularly focusing on conditions like Peripheral Artery Disease (PAD) and Diabetic Foot Ulcers (DFU). Their innovative approach seeks to enhance wound healing and prevent amputations through accurate and timely vascular assessments.

Industries

N/A

Nr. of Employees

small (1-50)

Moonrise Medical

295 Robinson St. Suite 100, Oakville, Ontario L6J 1G7, Canada

Awards

Funding (ceiling)

$496,778.28

Award Year

2025


Patents

Vascular flow diagnostic system

2024-02-20 • US-11903688-B2

View Details

Products

AI-enabled ultrasound device for peripheral vascular flow assessment

A medical device combining ultrasound imaging and AI analytics to quantify peripheral vascular hemodynamics, intended to aid diagnosis of PAD, assess diabetic foot ulcers, and guide revascularization.

Expertise Areas

  • Peripheral vascular diagnostics
  • Ultrasound imaging and biomarker discovery
  • AI/ML for medical imaging
  • Intraoperative hemodynamic monitoring
  • Show More (3)

Key Technologies

  • Ultrasound imaging
  • AI / machine learning for imaging
  • Hemodynamic flow measurement
  • Real-time monitoring systems
  • Show More (2)

Key People

Adam Gold

Chief Executive Officer

Abubaker Khalifa, MD

Chief Operating Officer

Jill Sommerset, RVT

Chief Scientific Officer


Featured In Technology Showcase

Automated Portable Ultrasound for Rapid Vascular Assessment in Combat Casualty Care: Moonrise Medical Inc.

Moonrise Medical Inc. is developing an automated portable ultrasound system for rapid vascular assessment and real-time blood-flow monitoring in combat casualty care. The project is supported through MTEC Award No. 24-01-MPAI-149.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.